Articles tagged with "Ankylosing Spondylitis"

Treating Early-Stage Spondyloarthritis May Prevent Disease Progression, Say Researchers at the ACR/ARHP Winter Rheumatology Symposium

Kimberly Retzlaff | April 2, 2014

Therapy with tumor necrosis factor inhibitors, nonsteroidal antiinflammatory drugs, ustekinumab in early stages of osteitis may halt molecular switching to bone-forming phenotype characteristic of SpA

Approval Expected for Apremilast

Richard Quinn | March 5, 2014

New drug shows promise in treating psoriatic arthritis, ankylosing spondylitis & psoriasis

Rheumatology Drug Updates

Michele B. Kaufman, PharmD, BCGP | March 1, 2014

Information on new approvals and medication safety that rheumatologists need to know

Paleopathology Uses Patients from the Past to Investigate Today’s Diseases

Bruce Rothschild, MD | February 1, 2014

Evidence of disease in prehistoric skeletons can provide clues to early characteristics of rheumatoid arthritis, calcium pyrophosphate deposition disease, and other joint disorders

Does Anti-Tumor Necrosis Factor-Alpha Increase Cardiovascular Burden?

Lara C. Pullen, PhD | January 14, 2014

Long-term use of TNFα inhibitors in patients with rheumatoid arthritis and ankylosing spondylitis is associated with both gains in fat mass and a shift in fat mass to the visceral region. (posted Jan. 14)

Rheumatology Drug Updates

Michele B. Kaufman, PharmD, BCGP | January 1, 2014

Information on new approvals and medication safety that rheumatologists need to know

Researchers Explore HLA-B27’s Role in the Development of Spondylitis

Will O’Brien, MD | June 14, 2013

New research reports on the increased sensitivity of human-HLA-B27 transgenic rat bone marrow monocytes to TNF-α stimulation and osteoclast differentiation. (posted June 27, 2013)

ACR/ARHP Annual Meeting 2012: Spondylarthritis Criteria Changing Landscape of the Disease

Thomas R. Collins | December 1, 2012

More finely tuned view of ankylosing spondylitis leads to better treatment, expert says

Rheumatology Drug Updates: Apremilast, Golimumab, and More

Michele B. Kaufman, PharmD, BCGP | November 1, 2012

Information on new approvals and medication safety rheumatologists need to know

A Few Acronyms and Indices in OMERACT

Prakash Pispati, MD | October 17, 2012

HAQ: Health Assessment Questionnaire DAS28: Disease Activity Score DAS: Psoriatic Arthritis: ACR Core Data Set and Disease Activity Score PsARC: Psoriatic Arthritis Response Criteria PSAI: Psoriasis Area and Severity Index SLEDAI: SLE Disease Activity Score BILAG: British Isles Lupus Activity Score SLAM: Systemic Lupus Activity Measure LAI: Lupus Activity Index ECLAM: European Consensus Lupus Activity…